Pharmaceutical News and Articles

Moderna’s New Flu Shot Shows Strong Results in Older Adults

TUESDAY, July 1, 2025 Moderna s new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major trial, the com

Monthly News Roundup - June 2025

Dupixent Approved in the U.S. as the First Targeted Medicine to Treat Patients with Bullous Pemphigoid Dupixent (dupilumab) has been approved for the treatment

UCB Announces Positive Results from GEMZ Phase 3 Study of Fenfluramine in CDKL5 Deficiency Disorder

Brussels, Belgium 27th June 2025 UCB, a global biopharmaceutical company, today announced that the phase 3 study investigating the safety and efficacy of adjunc

Breast Cancer Risk in Younger Women May Be Influenced by Hormone Therapy

Scientists at the National Institutes of Health (NIH) have found that two common types of hormone therapy may alter breast cancer risk in women before age 55. R

Amgen Announces Positive Topline Phase 3 Results for Bemarituzumab in Fibroblast Growth Factor Receptor 2b (FGFR2b) Positive First-line Gastric Cancer

Amgen (NASDAQ AMGN) today announced the Phase 3 FORTITUDE-101 clinical trial evaluating first-line bemarituzumab plus chemotherapy (mFOLFOX6) met its primary en

FDA Approves Expanded Indications for GE HealthCare’s Vizamyl PET Imaging Agent for Beta Amyloid Detection, Enabling More Precise Care for Alzheimer’s Patients

Emmaus Life Sciences Receives FDA Approval for Endari Label Enhancements

Unicycive Therapeutics Announces Receipt of Complete Response Letter for Oxylanthanum Carbonate for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis

Lower Risk of Alzheimer Disease Seen for Breast Cancer Survivors

Breast cancer survivors have a lower risk of Alzheimer disease (AD) compared with cancer-free controls, according to a study published online June 20 in JAMA Ne

FDA Approves Benlysta Autoinjector for Pediatric Patients With Active Lupus Nephritis

The U.S. Food and Drug Administration has approved an autoinjector of Benlysta (belimumab) for subcutaneous injection in patients 5 years of age with active lup